HB1617 establishes a new framework for “health innovation zones” in Maryland. The bill defines such zones as contiguous geographic areas with documented health disparities and poor health outcomes, including high rates of maternal and newborn complications and chronic or infectious disease, and that are populated by communities of color, low-income households, high-immigrant populations, or other economically disadvantaged communities. The zones are intended to be small enough that targeted incentives can meaningfully improve health outcomes and reduce racial, ethnic, geographic, and disability-related disparities.
Under the bill, a county’s local zoning authority may designate a health innovation zone if the area is a food or health care desert, has high concentrations of cancer, diabetes, heart disease, or hypertension, and has too few grocery stores, pharmacies, primary care providers, and specialty care providers. If a county makes such a designation, it must adopt incentives for those types of businesses to locate in the zone. The bill also requires the Prince George’s County Council to designate zones in the Blue Line Corridor and areas within two miles of the District of Columbia border, and allows additional zones there under the same health-disparity criteria.
The bill further directs the Governor, beginning in fiscal year 2028 and subject to budget limits, to include at least $5 million in the annual budget for the Maryland Economic Development Corporation (MEDCO) to encourage grocery stores, pharmacies, and medical providers to locate in Prince George’s County health innovation zones. MEDCO must begin providing funding on July 1, 2028, and seek additional funding sources as well. Businesses located in a health innovation zone established under the subtitle are exempt from local zoning and land use laws.
The bill’s impact would be to create a new state-law mechanism for targeted public health and economic development intervention in underserved communities, while also limiting local zoning control for certain businesses in designated zones. It would add new provisions to the Health-General Article and create a state-supported incentive program centered on Prince George’s County, with potential implications for land use, health care access, and retail food access.
The available vote history suggests the bill had substantial support in the House, passing third reading 98-34. No committee transcript is available here, so the broader discussion record is limited, but the structure of the bill suggests generally favorable sentiment toward addressing health disparities through place-based incentives. Likely points of contention include the mandatory Prince George’s County designations, the state funding commitment, and the exemption from local zoning and land use laws, which could raise concerns about local control, fiscal impact, and the scope of state intervention.
HB1617 would amend the Health-General Article by adding a new subtitle on health innovation zones, creating a county-level designation process and a Prince George’s County-specific program. It would require counties that designate such zones to adopt incentives for grocery stores, pharmacies, primary care providers, and specialty care providers, and it would exempt those entities from local zoning and land use laws when located in a designated zone. The bill also authorizes a state budget appropriation to MEDCO beginning in fiscal 2028 and directs MEDCO to support business development in Prince George’s County zones.
The bill appears to have been received positively overall, as reflected by its strong House passage on third reading by a 98-34 vote. The framing of the bill as a public health and economic development tool suggests support from members focused on health equity, access to care, and underserved communities. At the same time, the absence of transcript material limits the ability to identify detailed arguments, amendments, or negotiated compromises.
The main areas of potential contention are the bill’s mandatory treatment of Prince George’s County, the required state funding commitment to MEDCO, and the exemption of certain businesses from local zoning and land use laws. Supporters are likely to emphasize reducing health disparities, improving access to food and health care, and attracting needed services to underserved areas. Opponents or skeptics may focus on local autonomy, the fiscal obligation to the state budget, and whether zoning exemptions are the best way to achieve the bill’s public health goals.